24 results
8-K
EX-10.1
ANEB
Anebulo Pharmaceuticals Inc
6 Oct 23
Departure of Directors or Certain Officers
4:10pm
8-K
EX-10.1
ANEB
Anebulo Pharmaceuticals Inc
28 Sep 23
Departure of Directors or Certain Officers
6:17pm
8-K
EX-10.1
ANEB
Anebulo Pharmaceuticals Inc
8 Mar 23
Entry into a Material Definitive Agreement
8:00am
8-K
EX-10.1
cre9gai0l9zpbqzn
24 May 22
Anebulo Pharmaceuticals Appoints Kenneth Cundy, Ph.D., as Chief Scientific Officer
4:05pm
8-K
EX-10.1
rjm7bln ev4oz
5 Jan 22
Anebulo Pharmaceuticals Names Biotechnology Industry Executive Simon Allen
10:00am
S-1
EX-10.9
mzfegt1kvf3i3l
1 Apr 21
IPO registration
5:19pm
S-1
EX-10.6
ml3mt93 am3
1 Apr 21
IPO registration
5:19pm
S-1
EX-10.8
td7wuqq ekya2wb
1 Apr 21
IPO registration
5:19pm
S-1
EX-10.1
otytqi f8phs5zu
1 Apr 21
IPO registration
5:19pm
S-1
EX-10.5
xr9vj9rh1e 2nq4
1 Apr 21
IPO registration
5:19pm
S-1
EX-10.3
684rv forsi
1 Apr 21
IPO registration
5:19pm
S-1
EX-10.2
zdl7nr0
1 Apr 21
IPO registration
5:19pm
S-1
EX-10.7
fw40p7
1 Apr 21
IPO registration
5:19pm
S-1
EX-10.4
wg8o8p55s8e7h
1 Apr 21
IPO registration
5:19pm
DRS/A
EX-10.4
ucyw2xr j8or7db3p6
12 Mar 21
Draft registration statement (amended)
12:00am